Found: 123
Select item for more details and to access through your institution.
A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 1, p. 30, doi. 10.2500/aap.2021.42.200112
- By:
- Publication type:
- Article
Chronic toxicity of inhaled thymol in lungs and respiratory tracts in mouse model.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 5, p. 1, doi. 10.1002/prp2.516
- By:
- Publication type:
- Article
Pharmacokinetic study of thymol after intravenous injection and high‐dose inhalation in mouse model.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 5, p. 1, doi. 10.1002/prp2.515
- By:
- Publication type:
- Article
Increasing cannabis use: What we still need to know about its effects on the lung.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Minimally important differences in the Mahler’s Transition Dyspnoea Index in a large randomized controlled trial—results from the Scleroderma Lung Study.
- Published in:
- Rheumatology, 2009, v. 48, n. 12, p. 1537, doi. 10.1093/rheumatology/kep284
- By:
- Publication type:
- Article
Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 3, p. 714, doi. 10.1002/ijc.21413
- By:
- Publication type:
- Article
Comparison of Bronchial Effects of Nabilone and Terbutaline in Healthy and Asthmatic Subjects.
- Published in:
- 1983
- By:
- Publication type:
- Other
Induction and Regulation of the Carcinogen-Metabolizing Enzyme CYP1A1 by Marijuana Smoke and Δ<sup>9</sup>-Tetrahydrocannabinol.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2001, v. 24, n. 3, p. 339, doi. 10.1165/ajrcmb.24.3.4252
- By:
- Publication type:
- Article
Enrichment Strategies for Systemic Sclerosis–Interstitial Lung Disease Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1067, doi. 10.1164/rccm.202401-0246ED
- By:
- Publication type:
- Article
Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 501, doi. 10.1164/rccm.202303-0404LE
- By:
- Publication type:
- Article
Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later Life.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 348, doi. 10.1164/rccm.202307-1146ED
- By:
- Publication type:
- Article
Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2021, v. 31, n. 1, p. 1, doi. 10.1038/s41533-021-00255-7
- By:
- Publication type:
- Article
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Vaping Cannabis and Chronic Obstructive Pulmonary Disease.
- Published in:
- 2018
- By:
- Publication type:
- editorial
Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia.
- Published in:
- 2015
- By:
- Publication type:
- letter
Does Marijuana Pose Risks for Chronic Airflow Obstruction?
- Published in:
- Annals of the American Thoracic Society, 2015, v. 12, n. 2, p. 235, doi. 10.1513/AnnalsATS.201412-581ED
- By:
- Publication type:
- Article
Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease.
- Published in:
- Rheumatology, 2019, v. 58, n. 4, p. 567, doi. 10.1093/rheumatology/key151
- By:
- Publication type:
- Article
Interstitial lung disease points to consider for clinical trials in systemic sclerosis.
- Published in:
- Rheumatology, 2017, v. 56, p. v27, doi. 10.1093/rheumatology/kex203
- By:
- Publication type:
- Article
Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision Analysis.
- Published in:
- Medical Decision Making, 2008, v. 28, n. 6, p. 926, doi. 10.1177/0272989X08317015
- By:
- Publication type:
- Article
Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1757, doi. 10.1007/s40265-019-01198-7
- By:
- Publication type:
- Article
Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD.
- Published in:
- International Journal of COPD, 2023, v. 18, p. 1475, doi. 10.2147/COPD.S396549
- By:
- Publication type:
- Article
Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD.
- Published in:
- International Journal of COPD, 2023, v. 18, p. 1475, doi. 10.2147/COPD.S396549
- By:
- Publication type:
- Article
Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 3111, doi. 10.2147/COPD.S386463
- By:
- Publication type:
- Article
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 945, doi. 10.2147/COPD.S304182
- By:
- Publication type:
- Article
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease.
- Published in:
- International Journal of COPD, 2020, v. 15, p. 3105, doi. 10.2147/COPD.S273497
- By:
- Publication type:
- Article
Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy.
- Published in:
- International Journal of COPD, 2020, v. 16, p. 1225, doi. 10.2147/COPD.S244942
- By:
- Publication type:
- Article
Menthol cigarettes and health risks in Lung Health Study data.
- Published in:
- Nicotine & Tobacco Research, 2007, v. 9, n. 1, p. 101, doi. 10.1080/14622200601078418
- By:
- Publication type:
- Article
Is It Asthma, COPD, or Something In Between, and Does it Matter?
- Published in:
- Respiratory Care, 2012, v. 57, n. 8, p. 1354, doi. 10.4187/respcare.01970
- By:
- Publication type:
- Article
The Role of Tiotropium in the Hospital Management of Exacerbation of Chronic Obstructive Pulmonary Disease.
- Published in:
- Respiratory Care, 2008, v. 53, n. 12, p. 1657
- By:
- Publication type:
- Article
Smoking cessation in COPD: confronting the challenge.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity.
- Published in:
- Sensors (14248220), 2022, v. 22, n. 6, p. 2264, doi. 10.3390/s22062264
- By:
- Publication type:
- Article
Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: An updated review.
- Published in:
- Allergy & Asthma Proceedings, 2015, v. 36, n. 2, p. 105, doi. 10.2500/aap.2015.36.3835
- By:
- Publication type:
- Article
Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease: Results from a 1-Year Randomized Controlled Clinical Trial.
- Published in:
- Drugs, 2009, v. 69, n. 5, p. 549, doi. 10.2165/00003495-200969050-00004
- By:
- Publication type:
- Article
Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease: Results of a 6-Month Randomized Clinical Trial.
- Published in:
- Drugs, 2008, v. 68, n. 14, p. 1975, doi. 10.2165/00003495-200868140-00004
- By:
- Publication type:
- Article
The UCLA population studies of CORD: X. A cohort study of change in respiratory function Associated with Chronic Exposure to SOx, NOx, and Hydrocarbons.
- Published in:
- American Journal of Public Health, 1991, v. 81, n. 3, p. 350, doi. 10.2105/AJPH.81.3.350
- By:
- Publication type:
- Article
The use of nebulized pharmacotherapies during the COVID-19 pandemic.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620954366
- By:
- Publication type:
- Article
Acute and subacute bronchial effects of oral cannabinoids.
- Published in:
- Clinical Pharmacology & Therapeutics, 1984, v. 35, n. 1, p. 26, doi. 10.1038/clpt.1984.4
- By:
- Publication type:
- Article
Reversal of human lymphocyte β-adrenoceptor desensitization by glucocorticoids.
- Published in:
- Clinical Pharmacology & Therapeutics, 1982, v. 32, n. 5, p. 566, doi. 10.1038/clpt.1982.204
- By:
- Publication type:
- Article
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 10, p. 547, doi. 10.1002/acr2.11598
- By:
- Publication type:
- Article
Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 1, p. 8, doi. 10.1002/acr2.11206
- By:
- Publication type:
- Article
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II.
- Published in:
- ACR Open Rheumatology, 2020, v. 2, n. 6, p. 362, doi. 10.1002/acr2.11125
- By:
- Publication type:
- Article
Using Transitional Changes on High‐Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis–Related Interstitial Lung Disease.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 2, p. 316, doi. 10.1002/art.41085
- By:
- Publication type:
- Article
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 12, p. 2059, doi. 10.1002/art.41020
- By:
- Publication type:
- Article
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 7, p. 1451, doi. 10.1002/art.40114
- By:
- Publication type:
- Article
Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 11, p. 3016, doi. 10.1002/art.39289
- By:
- Publication type:
- Article
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients.
- Published in:
- 2006
- By:
- Publication type:
- journal article